<?xml version="1.0" encoding="utf-8"?>
    <rss version="2.0">
      <channel xmlns:content="http://purl.org/rss/1.0/modules/content/">
        <title>Frontiers in Surgery | Reconstructive and Plastic Surgery section | New and Recent Articles</title>
        <link>https://www.frontiersin.org/journals/surgery/sections/reconstructive-and-plastic-surgery</link>
        <description>RSS Feed for Reconstructive and Plastic Surgery section in the Frontiers in Surgery journal | New and Recent Articles</description>
        <language>en-us</language>
        <generator>Frontiers Feed Generator,version:1</generator>
        <pubDate>2026-05-13T12:31:23.03+00:00</pubDate>
        <ttl>60</ttl>
        <item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1782368</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1782368</link>
        <title><![CDATA[Poly-L-lactic acid (PLLA) in arm contouring: a prospective and blinded trial of Rennova® Elleva and Sculptra®]]></title>
        <pubdate>2026-05-08T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Bruna Souza Felix Bravo</author><author>Ana Luisa Leopoldino de Souza</author><author>Emmanuela Beatriz Vantini Barreiro</author><author>Airá Novello Vilar</author><author>Bárbara Fouraux Gouvea</author><author>Leonardo Gonçalves Bravo</author><author>Marina Ramos Baeta Neves</author>
        <description><![CDATA[BackgroundPoly-L-lactic acid (PLLA) is a biostimulatory filler used to improve dermal laxity and contour, yet comparative data between formulations for upper-arm rejuvenation remain scarce.MethodsIn this prospective, randomized, blinded split-arm trial, 20 adults received bilateral upper-arm injections with two PLLA formulations (Rennova® Elleva vs. Sculptra®). Outcomes included Subject and Physician Global Aesthetic Improvement Scales (S-GAIS, P-GAIS), ultrasonography (USG), skin elasticity, and transepidermal water loss (TEWL) through Day 120. Histological analyses in ten cases assessed skin thickness, inflammation, and crystalline residues.ResultsBoth products yielded marked enhancements in skin texture and arm contour with excellent tolerability. S-GAIS scores improved to 2.9 ± 0.67 at Day 120, with no differences between formulations (p > 0.99). P-GAIS scores similarly rose (Rennova® Elleva: 3.2 ± 0.98; Sculptra®: 3.3 ± 0.90; p = 0.86). Ultrasound findings confirmed dermal remodeling in both arms. By Day 120, USG value increased to 957 ± 209 with Rennova® Elleva (p = 0.049) and 938 ± 174 with Sculptra® (p = 0.92), with no between-group difference (p = 0.99). Skin elasticity increased significantly in both arms by Day 90 (Rennova® Elleva: 172 ± 35 to 191 ± 29, p = 0.035; Sculptra®: 165 ± 19 to 177 ± 24, p = 0.041), while TEWL remained stable. Skin thickness rose significantly (Rennova® Elleva: 2.06 ± 0.55 to 2.66 ± 0.53 mm, p = 0.039; Sculptra®: 1.80 ± 0.41 to 2.70 ± 0.69 mm, p = 0.0039), without between-group differences (p = 0.54). Histology showed sparse perivascular lymphocytes and occasional macrophages, with no granulomas or crystalline material.ConclusionsThis study suggests that both Rennova® Elleva and Sculptra® are effective, well-tolerated PLLA formulations that may be capable of producing meaningful aesthetic and biophysical improvements in upper-arm contour and skin quality within the first 120 days.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1821731</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1821731</link>
        <title><![CDATA[Use of axillary vascular grafts in prophylactic lymphovenous bypass: technical challenges and lessons learned]]></title>
        <pubdate>2026-05-08T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Jorge Flores Garcia</author><author>J. Michael Smith</author><author>Ramin Rajaii</author><author>Emily L. Geisler</author><author>Roman J. Skoracki</author><author>Min-Jeong Cho</author>
        <description><![CDATA[BackgroundBreast cancer–related lymphedema (BCRL) is a common and debilitating complication of axillary lymph node dissection (ALND), affecting approximately 1 in 5 patients. While preventive lymphatic surgeries such as prophylactic lymphovenous bypass (pLVB) performed at the time of ALND have been shown to decrease the risk of developing BCRL, success is frequently limited by inadequate recipient veins within the axilla. In this study, we report our experience with utilizing axillary vascular grafts harvested from within the axillary dissection field to perform pLVB in vein-depleted axillae to prevent the development of BCRL in patients undergoing ALND.MethodsA retrospective review was performed of breast cancer patients undergoing ALND with planned pLVB at a single institution. Patients in whom axillary vascular grafts were used to enable lymphatic reconstruction were included. Demographic, oncologic, operative, and graft-specific variables were collected. Outcomes included successful lymphatic reconstruction and development of BCRL, assessed using a standardized institutional surveillance protocol incorporating circumferential measurements or perometry.ResultsThirty-two patients had a mean age of 52.3 years (SD, 12.9) and median BMI of 26.9 kg/m2 (IQR, 23.8–28.7), with median follow-up of 15 months (IQR, 11–31). Of the 121 transected lymphatic vessels, interposition grafts were required for 74.8% of reconstructions. A total of 35 grafts (74.3% venous, 25.7% arterial) with median length of 5 cm (IQR, 4–6) were performed with a median of 3 pLVBs (IQR, 2–5) performed per patient. BCRL developed in 6 patients (18.8%) with an average follow-up of 21.3 months (IQR, 11−31); those affected had a higher mean number of lymph nodes removed (22.3 vs. 15.4; P < .05), and as a result, more graft-based pLVBs (median 4.5 vs. 2; P < .05).ConclusionAxillary-based vascular grafting is a versatile strategy that expands reconstructive capacity during pLVB without additional donor-site morbidity. This approach enables completion of lymphatic reconstruction in anatomically challenging, vein-depleted axillae and represents a practical adjunct for immediate lymphatic reconstruction in high-risk breast cancer patients.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1715967</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1715967</link>
        <title><![CDATA[Case Report: Acute pancreatitis obscured by paralytic ileus in a patient with extensive burns]]></title>
        <pubdate>2026-04-30T00:00:00Z</pubdate>
        <category>Case Report</category>
        <author>Hui Wang</author><author>Da Wang</author><author>Jun Liu</author>
        <description><![CDATA[Extensive burns are associated with numerous severe complications. While paralytic ileus is relatively common, the co-occurrence of acute pancreatitis (AP) is rare, clinically insidious, and highly fatal. Diagnosis is particularly challenging due to masking by critical illness and coexisting ileus. We present a 32-year-old male with 65% TBSA flame burns and inhalation injury, admitted in hypovolemic shock. Resuscitation followed Parkland protocol, and escharotomy was performed. On day 2, abdominal distension and reduced bowel sounds suggested paralytic ileus, managed with nasogastric decompression and parenteral nutrition. By day 5, epigastric pain developed. Serum amylase and lipase (peaking at 580.38 U/L) and urinary amylase were elevated. Abdominal CT and MRI confirmed AP. Treatment included strict nil-by-mouth, aggressive support, and somatostatin. Serum lipase normalized with clinical improvement, while urinary amylase remained elevated until day 13. The patient recovered fully after skin grafts and was discharged. This case underscores that AP can be a lethal burn complication often obscured by ileus. Serum lipase is more reliable than urinary amylase for diagnosis and monitoring, especially with concurrent kidney injury. Vigilance, timely imaging, and multimodal support are critical. Persistent urinary amylase may reflect renal dysfunction rather than ongoing pancreatitis.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1769996</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1769996</link>
        <title><![CDATA[Research progress on TWEAK/Fn14 signaling in chronic wound healing]]></title>
        <pubdate>2026-04-29T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Bo Liu</author><author>Weimin Wu</author><author>Weigang Hu</author><author>Huarong Zheng</author><author>Tianyao Lan</author>
        <description><![CDATA[Chronic wounds are characterized by persistent inflammation and altered microenvironments, exhibiting prolonged healing and difficult repair, presenting significant therapeutic challenges. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK), by binding to its receptor fibroblast growth factor-inducible 14 (Fn14), participates in cellular regulation, wound repair, and inflammatory response processes, playing an important role in chronic wound healing. This review summarizes the pathophysiological mechanisms of chronic wounds, the mechanisms of action of the TWEAK/Fn14 signaling pathway in chronic wound healing, and the latest research progress on its potential as a therapeutic target.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1787830</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1787830</link>
        <title><![CDATA[Commentary: Asymmetric adult-onset asthma with periocular xanthogranuloma associated with IgG4-related disease: a case report]]></title>
        <pubdate>2026-04-22T00:00:00Z</pubdate>
        <category>General Commentary</category>
        <author>Yue Cheng</author><author>Qianqian Mi</author><author>Dan Wang</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1762417</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1762417</link>
        <title><![CDATA[Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics]]></title>
        <pubdate>2026-04-20T00:00:00Z</pubdate>
        <category>Systematic Review</category>
        <author>Edward Akosah Danso</author><author>Malik Olatunde Oduoye</author><author>Williams Chukwuebuka Enuh</author><author>Umer Wamiq</author><author>Hafsa Shuja</author><author>Fnu Sawaira</author><author>Hareem Fatima</author><author>Sadia Tameez-ud-din</author>
        <description><![CDATA[BackgroundOrgan and tissue transplantation has transformed the management of end-stage organ failure, yet graft rejection remains a major barrier. Rejection arises from complex immune mechanisms involving MHC mismatch, T-cell allorecognition, and antibody-mediated injury. Advances in immunosuppressive therapy have improved graft survival, but significant challenges persist.AimThis scoping review synthesizes current insights into the immunological basis of graft rejection and evaluates conventional, biologic, and emerging immunosuppressive strategies. Particular attention is given to organ-specific differences and newer fields such as vascularized composite allografts (VCA) and xenotransplantation.MethodsA systematic literature search was conducted across PubMed, Google Scholar, Cochrane, and ClinicalTrials.gov (updated June 2025) following PRISMA guidelines. Studies addressing mechanisms of rejection, therapeutic innovations, and clinical outcomes in solid organ transplantation were included.ResultsRejection manifests in distinct forms: hyperacute rejection, though rare due to modern screening, remains catastrophic when pre-existing antibodies are present; acute rejection affects 10%–20% of patients within the first year, driven by both T-cell and antibody-mediated pathways; and chronic rejection, emerging months to years later, leads to progressive fibrosis, vasculopathy, and graft loss across organs. The degree of HLA mismatch consistently emerged as the strongest predictor of long-term survival. Conventional regimens of corticosteroids, calcineurin inhibitors, and antimetabolites remain foundational but are limited by nephrotoxicity, metabolic complications, and infection risk. Biologics such as basiliximab, belatacept, and rituximab have introduced more targeted suppression, while innovative approaches, including regulatory T-cell therapy, tolerogenic dendritic cells, gene-editing strategies, and nanotechnology-based drug delivery, show promise. Despite these advances, long-term therapy is challenged by 20%–70% patient non-adherence, heightened infection risk, and malignancy.ConclusionFuture strategies must emphasize personalized, biomarker-guided regimens, immune tolerance induction, and AI-driven diagnostics to achieve durable graft acceptance with minimal complications. Integration of consensus frameworks and precision medicine approaches will be essential to improving long-term graft survival and patient health.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1824889</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1824889</link>
        <title><![CDATA[A translational mechanistic synthesis of ischemia–reperfusion injury in experimental flap models toward free flap salvage]]></title>
        <pubdate>2026-04-20T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Ovunc Akdemir</author>
        <description><![CDATA[BackgroundIschemia–reperfusion (I/R) injury remains a principal biological determinant of partial or total flap failure in reconstructive microsurgery. Reperfusion paradoxically initiates a coordinated cascade involving reactive oxygen species generation, lipid peroxidation, neutrophil activation, endothelial dysfunction, and microvascular obstruction, ultimately propagating progressive tissue necrosis. Despite extensive experimental investigation, effective translation into perioperative free flap salvage strategies remains limited.MethodsA structured translational synthesis was conducted integrating institutional experimental flap I/R studies performed over two decades with systematically mapped external literature published between 2000 and February 2026. Study identification followed PRISMA-informed search principles to ensure methodological transparency. Data extraction adhered to ARRIVE 2.0 domains to standardize experimental quality assessment. Given predefined biological heterogeneity in flap type, ischemia duration, intervention timing, and outcome definitions, quantitative meta-analysis was not pursued. Instead, biologically stratified comparative analyses were performed, and biologically contextualized viability changes were descriptively evaluated within comparable severe ischemia subgroups to preserve mechanistic interpretability.ResultsAcross experimental platforms, effective interventions demonstrated a reproducible biological signature characterized by attenuation of lipid peroxidation, suppression of neutrophil-mediated inflammation, restoration of endogenous antioxidant defenses, and preservation of nitric oxide bioavailability. In a comparable severe ischemia epigastric island flap paradigm, trimetazidine, propionyl-L-carnitine, and lutein each demonstrated improved survival area relative to ischemic controls within their respective experimental contexts. Surgical conditioning strategies exhibited robust protection, with venous flap pre-arterialization and delay procedures achieving survival rates approaching near-complete viability in the respective model. However, these conditioning strategies are not directly transferable to acute free flap salvage scenarios and are primarily applicable to planned or staged reconstructive settings.ConclusionFlap I/R injury follows a reproducible oxidative stress–inflammation–microvascular dysfunction axis. Interventions targeting multiple components of this cascade appear to demonstrate a more reproducible protective pattern across severe ischemia conditions within their respective experimental contexts. These findings establish a translational mechanistic framework to guide rational adjunctive strategies in high-risk free flap protocols and support prospective clinical integration in microsurgical salvage scenarios. This synthesis is intended to guide mechanistic prioritization rather than imply direct interventional equivalence across models.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1704665</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1704665</link>
        <title><![CDATA[Surgical management of stage 3 and 4 pressure injuries in trauma patients using ovine forestomach matrix grafts: a prospective case series]]></title>
        <pubdate>2026-04-20T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Sophia M. Trinh</author><author>Kaitlyn Andre</author><author>Ada I. Özcan</author><author>Dhanushka S. Vitharana</author><author>Paige E. Deville</author><author>Joseph W. Mason</author><author>John P. Hunt</author><author>Alan B. Marr</author><author>Patrick P. Greiffenstein</author><author>Lance E. Stuke</author><author>Alison A. Smith</author>
        <description><![CDATA[IntroductionStage 3 and 4 pressure injuries (PIs) pose significant challenges in trauma patients. Surgical management aims to support improvements in tissue vitality and often relies on debridement and negative pressure wound therapy. The use of ovine forestomach matrix (OFM)-based grafts to augment existing surgical approaches may improve tissue quality prior to reconstruction or closure by secondary intention.MethodsThis prospective observational study is part of a larger Institutional Review Board-approved study (Registry: ClinicalTrials.gov. Clinical trial number: NCT05243966). The study enrolled patients with Stage 3 and 4 PIs between July 2022 and July 2024 at a single level 1 trauma center. The study’s primary endpoint was the incidence of postoperative complications and secondary endpoints included time to granulation tissue coverage and/or fill, percent area reduction, and number of OFM applications.ResultsNine participants (eight men, one woman) with a total of 12 PIs (25% Stage 3 and 75% Stage 4) were enrolled in the study. The mean surface area was 46 ± 24 cm2, and 10 of the 12 enrolled PIs included areas of tunneling and/or undermining. The median time to 50% granulation tissue was 2.0 (IQR: 1.5, 8.5) weeks and the median time to complete granulation tissue coverage was 6.5 (IQR: 2.0, 15.0) weeks. Tunneling or undermining was eradicated in 50% of PIs. The mean percent area reduction at the last recorded visit was 61% ± 30%. There were no postoperative complications.ConclusionThese results suggest that OFM-based grafts may serve as a valuable adjunct for the surgical management of late-stage PIs that are clinically challenging to heal.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1795247</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1795247</link>
        <title><![CDATA[Risk factors associated with postoperative necrosis after digital replantation: a systematic review and meta-analysis]]></title>
        <pubdate>2026-04-13T00:00:00Z</pubdate>
        <category>Systematic Review</category>
        <author>Feiyong Yu</author><author>Lingjing Lu</author><author>Yitong Zhou</author><author>Ruiying Wang</author><author>Hong Zheng</author>
        <description><![CDATA[BackgroundSystematically evaluate and quantitatively analyze risk factors associated with necrosis following replantation surgery for amputated fingers, providing evidence-based support for perioperative risk assessment and clinical decision-making.MethodsSystematically searched PubMed, Embase, Web of Science, Cochrane Library, and CNKI, Wan fang, VIP for all observational studies from indexing to January 1, 2026. Cohort studies reporting overall postoperative necrosis after finger replantation, as defined in the original studies, and its associated factors were included. The Newcastle–Ottawa Scale (NOS) was used to assess the methodological quality of included studies. Pooled effect sizes were extracted, and pooled odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated using a random-effects model.ResultsA total of 12 studies involving 3,645 patients were included. Meta-analysis results suggest smoking [OR = 3.48, 95% CI (1.96, 6.17)], preoperative ischemic time ≥8 h [OR = 2.25, 95% CI (1.43, 3.54)], crush injury [OR = 2.77, 95% CI (1.41, 5.43)], thrombosis [OR = 4.98, 95% CI (1.49, 16.67)], vein graft [OR = 1.56, 95% CI (1.19, 2.04)] may be associated with necrosis after digital replantationConclusionThis study suggests that smoking, preoperative ischemia duration ≥8 h, crush injury, thrombosis, and venous grafting may be associated with an increased risk of overall postoperative necrosis following finger replantation. These findings should be interpreted with caution because outcome definitions were not fully consistent across studies.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261290184.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1804506</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1804506</link>
        <title><![CDATA[Effects of aesthetic suturing on wound healing and scar formation in patients with traffic accident–related injuries]]></title>
        <pubdate>2026-04-13T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Jun Ren</author><author>Jing Diao</author><author>Ya-Qin Zhang</author><author>Chen Cai</author><author>Zi-Liang Gong</author><author>Bi-Bo Tang</author>
        <description><![CDATA[IntroductionTraffic accident–related lacerations frequently require urgent primary closure and may be complicated by irregular wound margins, heterogeneous contamination, and variable mechanical tension, all of which can influence scar maturation. This study evaluated the association between aesthetic suturing and clinical wound healing as well as scar-related outcomes in patients with traffic accident–related injuries.MethodsIn this retrospective observational study, 117 consecutive patients treated between March 2023 and September 2024 were categorized according to the closure approach documented at index repair (aesthetic suturing, n = 58; conventional suturing, n = 59). Data were extracted from electronic medical records using a standardized case report form. Outcomes included time to complete healing, primary healing, wound-related complications, healthcare utilization after discharge, and scar/aesthetic outcomes assessed by the Vancouver Scar Scale (VSS), symptom scores, and patient satisfaction.ResultsTime to complete healing and primary healing were comparable between groups, and no significant differences were observed in surgical site infection, dehiscence, hematoma/seroma, marginal ischemia/necrosis, or secondary procedures. Revisit/readmission was less frequent after aesthetic suturing. Scar outcomes favored aesthetic suturing, with substantially lower VSS total and domain scores, lower scar pain, and higher patient satisfaction; hypertrophic scar and contracture rates did not differ significantly. Subgroup analyses showed consistent VSS benefit without significant interaction across prespecified strata.DiscussionAesthetic suturing was associated with improved scar quality and patient-reported aesthetic outcomes without an apparent increase in short-term wound complications.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1807999</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1807999</link>
        <title><![CDATA[Editorial: Recent advancements and new developments in reconstructive surgery]]></title>
        <pubdate>2026-04-10T00:00:00Z</pubdate>
        <category>Editorial</category>
        <author>Joseph M. Escandón</author><author>Chihiro Matsui</author><author>Pedro Ciudad</author><author>Oscar J. Manrique</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1752335</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1752335</link>
        <title><![CDATA[Editorial: Reconstructive and aesthetic surgery of the face: new frontiers in research and clinical applications]]></title>
        <pubdate>2026-04-07T00:00:00Z</pubdate>
        <category>Editorial</category>
        <author>Mario Faenza</author><author>Roberto Grella</author><author>Giovanni Papa</author><author>Martin Iurilli</author><author>Marcello Molle</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1793884</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1793884</link>
        <title><![CDATA[Aesthetic abdominal contouring enhancement with combined abdominoplasty and circumferential liposuction in normal-BMI postpartum Asian women]]></title>
        <pubdate>2026-04-01T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Ruomeng Yang</author><author>Zhen Song</author><author>Jian Wang</author><author>Linxi Xia</author><author>Hongwei Liang</author>
        <description><![CDATA[BackgroundsAbdominoplasty constitutes a principal aesthetic procedure in plastic surgery, with relevance for postpartum women presenting with abdominal wall laxity. Nowadays, an increasing number of patients are undergoing abdominoplasty not merely to address a protruding abdominal appearance, but to pursue a waist-to-hip ratio that approaches an athletic physique.ObjectiveThis study aims to assess the clinical efficacy of combining abdominoplasty with liposuction within this patient population.MethodsThis retrospective study analyzed 160 postpartum women with BMI (22.1 ± 0.7 kg/m2) undergoing combined abdominoplasty and circumferential liposuction. Surgical steps included preoperative marking, tumescent liposuction of flanks, hip rolls, and upper abdomen, followed by abdominoplasty with rectus plication, progressive tension sutures, and meticulous umbilicoplasty. Outcomes were assessed via anthropometric measurements and Visual aid scoring questionnaire.ResultsWaist circumference significantly reduced from 90.9 cm to 80.4 cm postoperatively. Complications included seroma (3 cases), umbilical wound dehiscence (3 cases), and abdominal wound dehiscence (4 cases), all managed successfully. Patient satisfaction significantly improved postoperatively.ConclusionsCombined abdominoplasty and circumferential liposuction are safe and effective for abdominal contouring, achieving significant waistline refinement and high patient satisfaction. The integrated approach addresses both aesthetic and functional concerns with an acceptable complication profile.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1744865</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1744865</link>
        <title><![CDATA[Strategic application of multilayer fat grafting in facial rejuvenation: a retrospective study]]></title>
        <pubdate>2026-04-01T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Ruomeng Yang</author><author>Zhen Song</author><author>Jian Wang</author><author>Hongwei Liang</author>
        <description><![CDATA[BackgroundsFacial aging is characterized by complex volumetric changes involving soft tissue atrophy and skeletal remodeling. Autologous fat grafting has evolved as a primary technique, though unpredictable graft retention remains a challenge.ObjectiveThe study aims to provide the strategic application of differentially processed adipose products by matching material properties to anatomical requirements.MethodsThis retrospective study analyzed 105 patients undergoing facial fat grafting for age-related contour deformities. Adipose products, including high-density fat (HDF), adipose matrix complex (AMC), and stromal vascular fraction gel (SVF-gel), were injected into specific anatomical layers. Outcome assessments included clinical evaluation and standardized photographic documentation, Visual Analog scale, and Global Aesthetic Improvement Scale.ResultsAll patients achieved significant aesthetic improvement with no major complications. Early side effects resolved spontaneously within 3 weeks. Sixteen patients required secondary procedures due to partial volume absorption. SVF-gel demonstrated efficacy in periorbital rejuvenation and skin quality enhancement, while HDF and AMC provided stable structural support in deeper facial regions. Patient-reported satisfaction scores were 5.26 ± 1.84 preoperatively and 8.01 ± 1.09 postoperatively. Observer assessments using the Global Aesthetic Improvement Scale (GAIS, −1 to 3) yielded a postoperative score of 1.88 ± 0.65.ConclusionsThe targeted application of processed adipose products based on their biological properties and recipient site requirements enables effective, multilayer facial restoration. This approach addresses both volumetric deficits and skin quality concerns, offering a comprehensive solution for facial rejuvenation.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1769458</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1769458</link>
        <title><![CDATA[A meta-analysis of complications of thread lifting]]></title>
        <pubdate>2026-03-31T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Xiaocheng Zhou</author><author>Shubo Zhuang</author>
        <description><![CDATA[ObjectiveThis study aims to systematically review and perform a meta-analysis on the complications associated with thread lifting, a popular minimally invasive aesthetic procedure, to determine the incidence and types of adverse effects.MethodsA comprehensive literature search was conducted across major medical databases including PubMed, Embase, and Web of Science, covering all publications up to April 1, 2024. The search terms included “thread lift,” “suture lift,” “barbed suture,” “facelift,” and “nonsurgical facelift,” combined with “complications” or “adverse effects.” Only prospective or retrospective cohort studies, clinical randomized controlled trials (RCTs), and case series published in English were included. Studies were excluded if they were non-English, review articles, case reports, or conference abstracts with incomplete data. Study selection followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Data on authors, publication year, study design, sample size, patient demographics, follow-up duration, and complications were extracted and analyzed using RevMan 5.4. Heterogeneity among studies was assessed using the I2 statistic.ResultsOur comprehensive search initially identified 537 articles. After rigorous title and abstract screening, 213 articles were further assessed, with 26 studies ultimately included in the final analysis, representing a collective sample of 2,827 patients. The meta-analysis highlighted varying incidence rates of complications associated with thread lifts: swelling was reported in 34% of cases, visible or palpable threads in 10%, skin dimpling in 7%, and ecchymoses in 26%. The analysis also revealed high heterogeneity among the studies, with I2 values indicating substantial to high variability: swelling (I2 = 92%), skin dimpling (I2 = 76%), visible threads (I2 = 88%), and ecchymoses (I2 = 92%). Less common complications such as ear numbness and pinching sensation were reported in fewer studies, affecting approximately 5% and 7% of patients, respectively. Complications were further categorized into early postoperative events (occurring within the first four weeks, such as swelling, pain, and ecchymoses) and late-onset complications (persisting beyond four weeks, such as visible threads, skin dimpling, and thread migration), which may carry greater clinical significance.ConclusionThread lifting, while generally safe, does carry a risk of several complications, which vary widely in their occurrence. This meta-analysis provides a detailed overview of the risk profile of thread lifting procedures, highlighting the need for careful patient selection and technique mastery by practitioners. The findings underscore the importance of setting realistic patient expectations and preparing for potential adverse effects.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1728844</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1728844</link>
        <title><![CDATA[Feasibility and clinical utility of digital anthropometry for precise assessment of outcomes after post-bariatric reconstructive plastic surgery]]></title>
        <pubdate>2026-03-18T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Marco Alessandro Minetto</author><author>Andrea Margara</author><author>Elisabetta Quilico</author><author>Chiara Busso</author><author>Cristina Graziano</author><author>John A. Shepherd</author><author>Steven B. Heymsfield</author><author>Angelo Pietrobelli</author>
        <description><![CDATA[BackgroundTo investigate the feasibility and clinical validity of a digital anthropometric approach for body size and shape assessment in post-bariatric patients scheduled for plastic surgery.MethodsA convenience sample of 42 patients was recruited. Clinical evaluation, administration of outcome questionnaires, and digital anthropometric assessment were performed before and 3 months after abdominoplasty (in 26 patients) and thighplasty (in 16 patients).ResultsSignificant pre-post-intervention decreases in waist and hip circumferences were observed in the abdominoplasty subgroup: the median decrease was 3.3 cm (P < 0.0001) for the waist circumference and 2.6 cm (P = 0.002) for the hip circumference. Significant pre-post-intervention decreases in thigh circumferences and leg volumes were observed in the thighplasty subgroup: the median decreases of the left and right thigh circumferences were 1.7 cm (P = 0.001) and 1.5 cm (p = 0.003) and the median decreases of the left and right leg volumes were both 0.4 l (P values: 0.007 and 0.02). Significant pre-post-intervention improvements were also observed for both BODY-Q abdomen satisfaction scale scores and BODY-Q inner thighs satisfaction scale scores.ConclusionSurgical outcomes in patients undergoing abdominoplasty and thighplasty can be documented through clinimetric and digital anthropometric assessments. The availability of pre- and post-intervention avatars can be useful for both surgeons (for surgical planning and documentation of the surgical outcomes) and patients (for visualization of the surgical outcomes).]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1748242</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1748242</link>
        <title><![CDATA[Reconstruction of combined bone and soft tissue defects of the hand and foot with free superficial circumflex iliac artery perforator osteocutaneous flaps: a retrospective analysis]]></title>
        <pubdate>2026-03-13T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Jiadong Pan</author><author>Chenxi Zhang</author><author>Gaoxiang Yu</author><author>Luzhe Wu</author><author>Shanqing Yin</author><author>Xin Wang</author>
        <description><![CDATA[ObjectiveTo explore the surgical method and clinical efficacy of free superficial circumflex iliac artery perforator osteocutaneous flap in repairing combined bone and soft tissue defects of the hand and foot.MethodsFrom October 2011 to June 2023, 62 patients with combined bone and soft tissue defects of the hand and foot were treated with free superficial circumflex iliac artery perforator osteocutaneous flap, including 16 cases in the hand and 46 cases in the foot. The causes of injury included 18 cases of machine crush injury, 7 cases of traffic accident injury, and 37 cases of donor foot lesions after thumb/finger reconstruction. The area of skin defects ranged from 4 cm × 2 cm to 13 cm × 5 cm, and the length of bone and/or joint defects was 2 cm–8 cm. The flap harvesting range was 4.5 cm × 3.0 cm to 14 cm × 5.5 cm, and the volume of the iliac bone flap was 2 cm × 1 cm × 1 cm to 8 cm × 2.0 cm × 1.5 cm.ResultsPostoperatively, 58 flaps survived uneventfully, and 4 cases developed vascular crisis, all of which survived after symptomatic treatment. The postoperative follow-up period was 10–59 months. The appearance and texture of the flap were good in 49 cases, and 13 cases underwent secondary revision surgery due to flap bulkiness. Bone union time was ≤3 months in 46 cases, 3–6 months in 12 cases, and more than 6 months in 4 cases. The last x-ray examination showed that 56 cases had complete morphology of the iliac bone flap, 3 cases had bone resorption, 1 case had non-union, and 2 cases had secondary fractures. The scar at the hip donor site was well-concealed, without obvious deformity or pain.ConclusionThe superficial circumflex iliac artery perforator osteocutaneous flap is an effective method for repairing combined bone and soft tissue defects of the hand and foot, with significant advantages at the donor site, while also posing certain technical challenges.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1804333</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1804333</link>
        <title><![CDATA[Correction: Anterolateral thigh free flap using modified turbocharging method: a case report]]></title>
        <pubdate>2026-03-13T00:00:00Z</pubdate>
        <category>Correction</category>
        <author>Yooseok Ha</author><author>Donghyun Kim</author><author>Hyeokjae Kwon</author><author>Sunje Kim</author><author>Seung Han Song</author><author>Sang-Ha Oh</author><author>Joo-hak Kim</author><author>Ho Jik Yang</author><author>Hyunwoo Kyung</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1752461</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1752461</link>
        <title><![CDATA[Latissimus dorsi flap: a comprehensive systematic review of traditional and novel applications]]></title>
        <pubdate>2026-03-13T00:00:00Z</pubdate>
        <category>Systematic Review</category>
        <author>María García-García</author><author>Belén Andresen-Lorca</author><author>Alessandro Thione</author><author>Pedro Alvedro-Ruiz</author><author>Arantxa Blasco-Serra</author><author>Eva M. González-Soler</author><author>Alfonso A. Valverde-Navarro</author>
        <description><![CDATA[BackgroundThe latissimus dorsi (LD) flap is among the most adaptable and extensively employed techniques in reconstructive surgery, providing a dependable solution for addressing a wide range of defects. Although traditionally employed for soft-tissue coverage, its indications have progressively expanded to include complex and functional reconstructions. The aim of this review was to provide a comprehensive, indication-based overview of both traditional and emerging applications of the LD flap reported in the literature.MethodA systematic review was conducted in accordance with PRISMA guidelines, analysing published applications of the LD flap in reconstructive surgery. An initial search was performed up to July 30, 2024, and subsequently updated during manuscript revision to include studies published through January 10, 2026. Two independent reviewers examined the selected articles, individually extracting the relevant data, which was later combined and contrasted. Given the descriptive aim of the review, no statistical analysis was performed.ResultsA total of 188 full-text articles were included. Based on anatomical location, indications were categorized into breast, head and neck, thorax and back, abdomen and pelvis, and upper and lower extremity reconstruction. Both coverage and functional applications were identified. Functional reconstructions included innervated and non-innervated LD flaps used for facial reanimation, limb motor restoration, urologic reconstruction (including phalloplasty and detrusor myoplasty), diaphragmatic reconstruction, and other dynamic applications. Pedicled LD flaps were predominantly reported for anatomically adjacent defects, whereas free LD flaps were more commonly used for distant or complex reconstructions.ConclusionsThe latissimus dorsi flap can be configured in multiple forms to address defects across nearly all anatomical regions. Contemporary literature demonstrates a clear evolution toward functional and indication-driven applications, supported by advances in microsurgical techniques and muscle reinnervation. This descriptive synthesis provides a structured overview of reported indications and may assist surgeons in selecting reconstructive strategies based on anatomical and functional objectives.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fsurg.2026.1771200</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fsurg.2026.1771200</link>
        <title><![CDATA[Randomized controlled trial of immediate alveolar ridge preservation for bone and soft tissue aesthetics after tooth extraction]]></title>
        <pubdate>2026-03-12T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Yi-Ye Zhou</author><author>Nan Li</author><author>Yan Gao</author><author>Hui Chen</author>
        <description><![CDATA[ObjectiveThis study aimed to evaluate the long-term outcomes of alveolar ridge preservation (ARP) on soft tissue morphology, correlate them with underlying bone changes, and assess its clinical value. It directly compared alveolar bone preservation and soft tissue aesthetics between ARP and conventional tooth extraction.MethodsIn this prospective randomized controlled trial, sixty patients were randomly assigned (1:1) via sealed envelopes to a control group (conventional extraction) or an ARP group (immediate grafting with β-TCP and a collagen membrane). Over a 12-month follow-up, alveolar bone height and width changes were measured using CBCT. Soft tissue morphology was examined via plaster models, and aesthetics were evaluated using a 10-point scoring system for color and morphology.ResultsBaseline characteristics were comparable between groups. After 12 months, the control group showed significantly greater bone resorption in height (1.3 mm) and width (1.7 mm) compared to the ARP group (0.7 mm and 1.1 mm, respectively; P < 0.001). Soft tissue contours were significantly better in the ARP group (50.0% smooth, 50.0% mild abnormalities) than in the control group (33.3% margin disruption, 60.0% moderate irregularities; P < 0.001). A strong negative correlation was found between aesthetic scores and bone resorption (P < 0.001). The ARP group also achieved significantly higher soft tissue color (7.8 ± 0.5) and morphological scores (7.7 ± 0.6) than the control group (6.1 ± 0.6 and 5.9 ± 0.7; P < 0.001).ConclusionsImmediate ARP using β-TCP and a collagen membrane significantly reduces alveolar bone resorption, better maintains soft tissue morphology and aesthetics, and provides a superior foundation for future implant rehabilitation, demonstrating substantial clinical value.]]></description>
      </item>
      </channel>
    </rss>